Skip to main navigation

Investors
News Releases
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
IR Resources

News Releases

News Releases

Year

August 6, 2018

Harpoon Therapeutics Treats First Patient with HPN424 in Phase 1 Clinical Trial of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients

June 26, 2018

Immunotherapy Pioneer and Serial Biotech Entrepreneur Patrick Baeuerle to Present Compelling Data from Harpoon Therapeutics’ Biotherapeutics Platform at the 2018 European Congress on Biotechnology

April 16, 2018

Harpoon Therapeutics Launches Immuno-Oncology Pipeline with Compelling Data from Lead Programs at the 2018 American Association for Cancer Research (AACR) Annual Meeting

October 26, 2017

Harpoon Therapeutics Expands Management Team

October 18, 2017

AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration

May 25, 2017

Harpoon Therapeutics Announces Completion Of $45M Series B Financing

May 4, 2017

Harpoon Therapeutics Appoints Che-Leung Law, Ph.D., as Vice President, Translational Medicine

January 26, 2017

Harpoon Therapeutics Appoints William E. Picht, Jr. as Chief Financial Officer

December 13, 2016

Harpoon Therapeutics Appoints Gerald McMahon, Ph.D., as President and CEO

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Email Alerts

RSS Feeds

Contact IR

Search

© 2019. Harpoon Therapeutics, Inc. All rights reserved.

Search Investor Relations